Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities

  • Thomson A
  • Maltezos S
  • Paliokosta E
  • et al.
N/ACitations
Citations of this article
122Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Attention deficit hyperactivity disorder (ADHD) is increasingly recognised as occurring in people with intellectual disability (ID), although treatment of ADHD in this population has not ben tested widely. Risperidone has been used to treat ADHD in people with ID, although the evidence for its effectiveness is unclear.

Cite

CITATION STYLE

APA

Thomson, A., Maltezos, S., Paliokosta, E., & Xenitidis, K. (2009). Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd007011.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free